Biotech, Medtech & eHealth

Unique expertise to help Biotech, Medtech & eHealth
innovators, at any stage of their development

Building on 25+ years of passion & experience, we have developed a unique combination of capabilities in strategy, financial advisory & transactions

Experts in maximizing the value of your company & assets, leveraging our deep understanding of Science & Business

We guide you to build your Spin Off or Start Up

  • Assessment of preclinical & clinical data
  • Assessment of IP package
  • Business plan development
  • Funding strategy
  • Access & commercialization strategy

We partner with you to maximize the value of your asset

  • From discovery / pre-clinical to Investigational New Drug (IND)
  • Clinical development strategy, including target indication prioritization
  • Regulatory strategy including specific pathways and status
  • Value maximization / De-risking strategy

We help you commercialize your assets across key markets

  • Most appropriate commercialization approach
  • Business model design and customization to market specificities
  • Go-to-Market model (Build / Buy / Partner)
  • Market Access & Pricing strategy

Experts in transforming your innovation into a compelling equity story, leveraging our knowledge of investors

We help you to define the best value creation pathway of your innovation

  • Definition of value inflection points
  • Exit strategy & return for investors assessment

We support you throughout your fundraising journey

  • Review, challenge & extract the value of your data set
  • Reviewing / Building of Business Plan
  • Customized package to create interest & convince investors
  • Coaching for investor pitch
  • Investor prioritization according to funding strategy
  • Full support until closure of fundraising

Partners throughout your transaction journey, leveraging our negotiation skills & relationship with pharma companies

We ensure you make the most out of partnering deals / asset sales

  • Review, challenge & extract the value of your data set
  • Asset valuation (including primary research outcomes)
  • Preparation of appealing materials to create interest & convince partners
  • Access to a vast network of relevant partners across Pharmaceutical & Medical Device industries
  • Prioritize & target the best partners
  • Clinical development strategy, including target indication prioritization
  • Regulatory strategy including specific pathways & status
  • Value maximization / De-risking strategy

We support you on your M&A journey for a successful company/asset acquisition or sale

  • Vendor Due Diligence
  • Company valuation
  • Access to vast network of buyers across Private Equity, Pharmaceutical & Medical Device industries
  • Prioritize & target the best buyers
  • Full support from first contact through deal closing

They havetrusted us

trust

Abivax

Afyren

Aimmune

Alnylam

Beigene

Biomunex

Butterfly Therapeutics

Clevexel

Cold Genesys

DBV Technologies

Dermavant

Edwards Lifesciences

EverImmune

FreeOx

Galapagos

Gabi SmartCare

Galapagos

GamaMabs

Genosafe

Gustave Roussy Transfer

Innate Pharma

Insulet

I-Sep

Inventiva

ITCC

Locemia Solutions

Macopharma

MedinCell

Metronom Health

Neos Sugery

Nervosave

Neurim

Nexbiome

Orano Med

OSE Immunotherapeutics

Parean Biotech

PDC*Line

Pelago Biosciences

Perha Pharmaceuticals

Prometheus

Seattle Genetics

TreeFrog Therapeutics

Valbiotis

Vaxinano

Yposkesi

Ziwig

Why chooseAEC Partners ?

Strong scientific, clinical, market access & commercial expertise

Vast network of Pharmaceutical, Medical Device companies & Investors

Track record in supporting Biotech, Medtech & eHealth companies for 25+ years

Flexible remuneration model

Some of the transactionswe have supported